Elon Musk: MRI Can Accurately Assess Brain Capacity, Brain is a Biological Computer Like Silicon-Based Computers
Elon Musk stated that the brain is a biological computer, similar to silicon-based computers, with significant differences in processing capabilities and specialized skills among individuals. He believes that the potential capabilities of any brain can be inferred with high precision using MRI. He wrote that Neuralink must deeply understand the brain to effectively interface, leaving no room for empty talk.
The company has implanted a coin-sized N1 device in the skulls of paralyzed patients, using 1,024 electrodes to read the motor cortex's action potentials, which are wirelessly transmitted after on-chip compression and converted into a cursor or clicks by a model. The first implant recipient, Noland Arbaugh, uses it to browse the internet and play chess. Pre-surgery functional MRI located the hand and arm movement areas, which is part of the surgical planning, not a score for intelligence based on a structural image.
Musk has compared the brain to a computer for many years. Interface companies seek decodable discharge patterns and implantation coordinates that avoid blood vessels; "processing capacity can be measured with high precision by MRI" is another claim, but the article does not provide methods, errors, or peer-reviewed datasets. Cognitive neuroscience does show correlations between brain volume, connectomics, and certain test scores, but correlation does not equal high-precision predictions of individual capabilities, nor can it solely determine social stratification.
Neuralink's publicly stated goals include increasing human-machine bandwidth and long-term discussions about communication between humans and models, and between humans, with less language compression. The bandwidth narrative serves the expansion of implantation indications: from motor decoding to higher throughput. If MRI is framed as a capacity scale, it would transform imaging from a surgical tool into a screening tool, which is not under the same regulatory documents as existing medical devices.
In market mechanisms, the sellers are interface companies that need to portray the brain as measurable hardware, while the buyers are focused on implantation progress and the founder's worldview in the attention market. Event-driven discourse is rhetoric, not a new experimental endpoint. Funding still looks at electrode stability, infection rates, and bits per second, not the epistemology of this post. Beneficiaries are the implantation pipelines that tie pre-surgical imaging and surgical robots together; under pressure are public discussions that moralize or politicize intellectual differences, and misinterpret relevance as diagnosis.
Source: Public Information
ABAB AI Insight
Musk's characterization of the brain as a computer serves as an engineering blueprint for interface companies: it has inputs and outputs, power consumption, and individual differences. Neuralink's actual delivery is the action potential channel of the motor cortex, not an MRI IQ score. Pre-surgical functional imaging is used to locate hand representations to avoid incorrect targeting; upgrading it to "high-precision capability assessment" borrows medical localization language into psychometrics. The company can claim "no room for empty talk," referring to the need for electrodes to be placed in discharge-capable tissue, not suggesting that society can label processing capabilities based on imaging.
The capital pathway remains indications and bandwidth. Cursor control for paralyzed patients is the first billable, regulatory-reportable route; higher throughput communication is the next storyboard. If MRI capabilities are seriously productized, they will encounter discrimination reviews related to employment, education, and insurance, which is not the current reimbursement code for N1. Framing differences as "significant and measurable" serves another narrative: human brains are uneven, thus requiring interfaces to supplement bandwidth, rather than debating whether they should be measured.
Analogies can be seen in phrenology using skulls to measure abilities, intelligence tests entering immigration and military contexts, and polysomnography evolving from research instruments to commercial screening. The industry stage is that brain-machine interfaces can only stably read motor intentions, far from providing court-level proof of individual capabilities based on structural images. Those who treat relevance as precision will collide with measurement ethics at the regulatory level, rather than just facing surgical complications.
Structural judgment belongs to the struggle for definitional authority before technological substitution. The mechanism is: first define the organ as a computer, then define imaging as a benchmark test, and the interface slides from medical devices to capability infrastructure. Once precision claims leave the confidence intervals of papers, the contention is not over electrode density, but who has the right to read an MRI and say, "this brain can probably do this."
ABAB News · Cognitive Law
Imaging that can locate motor areas does not equate to scoring the brain
Defining organs as computers is to provide a construction blueprint for interfaces
Once measurement precision leaves the papers, the contention is over who has the right to label